Nerve Decompression and Restless Legs Syndrome: A Retrospective Analysis
暂无分享,去创建一个
[1] J. Connor,et al. Iron and restless legs syndrome: treatment, genetics and pathophysiology. , 2017, Sleep medicine.
[2] K. Chaudhuri,et al. Practice guideline summary: Treatment of restless legs syndrome in adults , 2016, Neurology.
[3] Ravi Gupta,et al. A double-blind, randomized, controlled trial to compare the efficacy and tolerability of fixed doses of ropinirole, bupropion, and iron in treatment of restless legs syndrome (Willis–Ekbom disease) , 2016, Annals of Indian Academy of Neurology.
[4] A. Walters,et al. Validation of the Kohnen Restless Legs Syndrome-Quality of Life instrument. , 2016, Sleep medicine.
[5] W. Oertel,et al. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. , 2016, Sleep medicine.
[6] James C. Anderson. Common Fibular Nerve Compression: Anatomy, Symptoms, Clinical Evaluation, and Surgical Decompression. , 2016, Clinics in podiatric medicine and surgery.
[7] N. Cuellar,et al. Peripheral diabetic neuropathy or restless legs syndrome in persons with type 2 diabetes mellitus: Differentiating diagnosis in practice , 2015, Journal of the American Association of Nurse Practitioners.
[8] L. Webster. Opioid-Induced Constipation. , 2015, Pain medicine.
[9] S. Bhoi,et al. Neuropathy in a cohort of restless leg syndrome patients , 2015, Journal of Clinical Neuroscience.
[10] S. Hollingworth,et al. Dopamine Agonists: Time Pattern of Adverse Effects Reporting in Australia , 2015, Drugs - Real World Outcomes.
[11] M. Kon,et al. The effect of lower extremity nerve decompression on health‐related quality of life and perception of pain in patients with painful diabetic polyneuropathy: a prospective randomized trial , 2015, Diabetic medicine : a journal of the British Diabetic Association.
[12] L. Wilkins. MRI measurement of brain iron in patients with restless legs syndrome , 2015, Neurology.
[13] Richard P Allen,et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. , 2014, Sleep medicine.
[14] E. Kocabicak,et al. Restless Leg Syndrome and Sleep Quality in Lumbar Radiculopathy Patients , 2014, Behavioural neurology.
[15] Yongmin Chang,et al. Altered white matter integrity in primary restless legs syndrome patients: diffusion tensor imaging study , 2014, Neurological research.
[16] R. P. Allen,et al. Comparison of Pregabalin with Pramipexole for Restless Legs Syndrome , 2014 .
[17] M. Zobeiri,et al. Restless Leg Syndrome in Diabetics Compared with Normal Controls , 2014, Sleep disorders.
[18] A. Kume. Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose? , 2014, Neuropsychiatric disease and treatment.
[19] J. Winkelmann,et al. Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension , 2013, The Lancet Neurology.
[20] Jun Shi,et al. Evaluation of the clinical efficacy of multiple lower-extremity nerve decompression in diabetic peripheral neuropathy , 2013, British journal of neurosurgery.
[21] A. Rader,et al. Low long-term risk of foot ulcer recurrence after nerve decompression in a diabetes neuropathy cohort. , 2013, Journal of the American Podiatric Medical Association.
[22] M. Narita,et al. Differential activation of the μ‐opioid receptor by oxycodone and morphine in pain‐related brain regions in a bone cancer pain model , 2013, British journal of pharmacology.
[23] Ravi Gupta,et al. Restless Legs Syndrome: a common disorder, but rarely diagnosed and barely treated--an Indian experience. , 2012, Sleep medicine.
[24] A. Dellon,et al. A Positive Tinel Sign as Predictor of Pain Relief or Sensory Recovery after Decompression of Chronic Tibial Nerve Compression in Patients with Diabetic Neuropathy , 2012, Journal of Reconstructive Microsurgery.
[25] L. Ferini-Strambi,et al. Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis‐Ekbom Disease): Results from a prospective, multicenter study over 66 weeks , 2012, Movement disorders : official journal of the Movement Disorder Society.
[26] J. Connor,et al. Profile of altered brain iron acquisition in restless legs syndrome. , 2011, Brain : a journal of neurology.
[27] J. Kalita,et al. Treatment of restless legs syndrome with pregabalin: A double-blind, placebo-controlled study , 2011, Neurology.
[28] J. Tolson,et al. A 52-Week Study of Gabapentin Enacarbil in Restless Legs Syndrome , 2011, Clinical neuropharmacology.
[29] Xiang Gao,et al. Restless legs syndrome and Parkinson's disease in men , 2010, Movement disorders : official journal of the Movement Disorder Society.
[30] Y. Rajabally,et al. Restless legs syndrome in chronic inflammatory demyelinating polyneuropathy , 2010, Muscle & nerve.
[31] G. Gigli,et al. Effects of Restless Legs Syndrome on Quality of Life and Psychological Status in Patients With Type 2 Diabetes , 2010, The Diabetes educator.
[32] Barry T. Peterson,et al. A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome. , 2009, Sleep medicine.
[33] S. Evers,et al. Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based survey , 2009, Journal of Neurology.
[34] A. Walters,et al. Gabapentin Enacarbil in Restless Legs Syndrome: A Phase 2b, 2-Week, Randomized, Double-Blind, Placebo-Controlled Trial , 2009, Clinical neuropharmacology.
[35] E. Lainey,et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. , 2009, Journal of neurology, neurosurgery, and psychiatry.
[36] Ekbom Ka. Restless legs; a report of 70 new cases. , 2009 .
[37] B. Todorich,et al. Oligodendrocytes and myelination: The role of iron , 2009, Glia.
[38] R. Postuma,et al. Is there a higher risk of restless legs syndrome in peripheral neuropathy? , 2009, Neurology.
[39] R. Allen,et al. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset. , 2008, Sleep medicine.
[40] K. Chaudhuri,et al. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial. , 2008, Sleep medicine.
[41] W. Oertel,et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial , 2008, The Lancet Neurology.
[42] G. Comi,et al. Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage , 2008, Multiple sclerosis.
[43] G. Gigli,et al. Association of restless legs syndrome in type 2 diabetes: a case-control study. , 2007, Sleep.
[44] J. Lefaucheur,et al. Restless legs syndrome is frequently overlooked in patients being evaluated for polyneuropathies , 2007, European journal of neurology.
[45] F. Gemignani,et al. Restless legs syndrome associated with peripheral neuropathy , 2007, European journal of neurology.
[46] S. Calzetti,et al. Restless legs syndrome in diabetic neuropathy: a frequent manifestation of small fiber neuropathy , 2007, Journal of the peripheral nervous system : JPNS.
[47] G. Plazzi,et al. Augmentation of restless legs syndrome with long‐term tramadol treatment , 2007, Movement disorders : official journal of the Movement Disorder Society.
[48] A. Bentley,et al. Can the Sensory Symptoms of Restless Legs Syndrome Be Assessed Using a Qualitative Pain Questionnaire? , 2007, The Clinical journal of pain.
[49] C. Halldin,et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. , 2006, Brain : a journal of neurology.
[50] M. Partinen,et al. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study. , 2006, Sleep medicine.
[51] W. Ondo,et al. Association between restless legs syndrome and essential tremor , 2006, Movement disorders : official journal of the Movement Disorder Society.
[52] A. Dolphin,et al. A short history of voltage‐gated calcium channels , 2006, British journal of pharmacology.
[53] G. Deuschl,et al. Idiopathic restless legs syndrome: abnormalities in central somatosensory processing. , 2005, Journal of neurology.
[54] Damien Dauphinee,et al. Morphological and functional changes in the diabetic peripheral nerve: using diagnostic ultrasound and neurosensory testing to select candidates for nerve decompression. , 2005, Journal of the American Podiatric Medical Association.
[55] Richard P Allen,et al. Restless legs syndrome prevalence and impact: REST general population study. , 2005, Archives of internal medicine.
[56] Y. Lo,et al. Restless hand symptoms in carpal tunnel syndrome , 2004, International journal of clinical practice.
[57] W. Paulus,et al. Why do restless legs occur at rest?—pathophysiology of neuronal structures in RLS. Neurophysiology of RLS (part 2) , 2004, Clinical Neurophysiology.
[58] M. Burns,et al. Case-Control Study , 2020, Definitions.
[59] J. Connor,et al. Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome , 2004, Journal of the Neurological Sciences.
[60] Richard P Allen,et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. , 2004, Sleep medicine.
[61] L. Ferini-Strambi,et al. Epidemiology and clinical findings of restless legs syndrome. , 2004, Sleep medicine.
[62] Richard P Allen,et al. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. , 2004, Sleep.
[63] R. Vetrugno,et al. Restless legs syndrome: an historical note. , 2004, Sleep medicine.
[64] J. Beard. Iron deficiency alters brain development and functioning. , 2003, The Journal of nutrition.
[65] Richard P Allen,et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. , 2003, Sleep medicine.
[66] 角田 明良,et al. 結腸癌術後の早期離床・早期経口摂取に関するProspective Randomized Trial , 2002 .
[67] A. Walters,et al. Long‐Term follow‐up on restless legs syndrome patients treated with opioids , 2001, Movement disorders : official journal of the Movement Disorder Society.
[68] M. Kryger,et al. Sleep complaints and restless legs syndrome in adult type 2 diabetics. , 2001, Sleep medicine.
[69] J. Beard,et al. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain , 2001, Pharmacology Biochemistry and Behavior.
[70] C. Bassetti,et al. Restless Legs Syndrome: A Clinical Study of 55 Patients , 2001, European Neurology.
[71] J. McArthur,et al. Subclinical sensory neuropathy in late-onset restless legs syndrome , 2000, Neurology.
[72] J. Heffner,et al. Transverse myelitis associated with restless legs syndrome and periodic movements of sleep responsive to an oral dopaminergic agent but not to intrathecal baclofen. , 2000, Sleep.
[73] M. Kryger,et al. Restless legs syndrome in 218 patients: associated disorders. , 2000, Sleep medicine.
[74] A. Vinik. Diabetic neuropathy: pathogenesis and therapy. , 1999, The American journal of medicine.
[75] J. Matheson,et al. Restless legs syndrome in patients with polyneuropathy , 1996, Muscle & nerve.
[76] J. O’Hare,et al. Prevalence and forms of neuropathic morbidity in 800 diabetics , 1994, Irish journal of medical science.
[77] F. Lewis. The role of the saphenous nerve in insomnia: a proposed etiology of restless legs syndrome. , 1991, Medical hypotheses.
[78] D. Ilstrup,et al. A Double-blind, Placebo-Controlled Study , 2017 .
[79] James C. Anderson. Anatomy, Symptoms, Clinical Evaluation, and Surgical Decompression , 2016 .
[80] B. Liu,et al. Pramipexole for Chinese people with primary restless legs syndrome: a 12-week multicenter, randomized, double-blind study. , 2015, Sleep medicine.
[81] M. Contini,et al. Painful polyneuropathy associated with restless legs syndrome. Clinical features and sensory profile. , 2013, Sleep medicine.
[82] W. Kremers,et al. Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain. , 2008, Current medical research and opinion.
[83] R. Domínguez,et al. [Restless legs syndrome in Fabry disease: clinical feature associated to neuropathic pain is overlooked]. , 2007, Revista de neurologia.
[84] R. Michael Alvarez,et al. Web-Based Survey , 2005 .
[85] Richard P Allen,et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. , 2003, Sleep medicine.
[86] J. Connor,et al. Relationship of iron to oligodendrocytes and myelination. , 1996, Glia.
[87] P C Bucy,et al. Historical note , 1984, Surgical neurology.
[88] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .
[89] T. Willis,et al. The London practice of physick , 1973 .
[90] H. P. Teglbjaerg. Pathogenesis and therapy. , 1954, Acta psychiatrica et neurologica Scandinavica.
[91] K. Ekbom. Restless legs; a report of 70 new cases. , 1950, Acta medica Scandinavica. Supplementum.
[92] G. A. Moore,et al. randomised double blind placebo controlled trial , 2022 .